- Umicore’s first half of 2025 adjusted earnings per share (EPS) came in at €0.56, which was below the estimate of €0.61.
- Reported net income for the first half of the year was €136.7 million, surpassing the estimate of €122.8 million.
- The company’s net debt stood at €1.83 billion, better than the estimated €1.98 billion.
- Umicore expects the full year 2025 adjusted EBITDA to be between €790 million and €840 million, in line with prior upgraded guidance.
- An anticipated year-on-year EBITDA increase of at least €100 million is expected for 2025 due to ongoing efficiency improvements.
- Analyst recommendations include 5 buy ratings, 12 hold ratings, and 2 sell ratings.
A look at Umicore SA Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 3 | |
| Growth | 2 | |
| Resilience | 2 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts using the Smartkarma Smart Scores indicate a promising long-term outlook for Umicore SA, a materials technology company. With a strong momentum score of 5, Umicore is showing positive signs of growth and upward movement in the market. While the growth and resilience scores are moderate at 2, the company’s value and dividend scores stand at 3, reflecting stability and potential for returns. Umicore’s diverse operations in advanced materials, precious metal products, catalysts, and zinc specialties across the globe position it well for future growth.
Umicore SA‘s overall outlook, as per the Smartkarma Smart Scores, highlights a company with solid momentum and value, supported by stable dividend payouts. Despite moderate scores in growth and resilience, Umicore’s global presence and focus on advanced materials technology bode well for its future prospects. Investors may view Umicore as a company with growth potential and a steady performance track record in its industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
